Skip to main content
Equibles

PROSTARM · Prostarm Info Systems Limited

Use PROSTARM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PROSTARM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
131.30 INR -4.45 (-3.28%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 9294 Avg daily vol (3M) 16.27K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close131.30 INR Open134.00 INR Day130.50–135.40 INR 52W close115.35–194.55 INR Avg vol 30d15K Last earningsNov 12, 2026 DataJun 2025–Nov 2026

Latest documents

2026
Nov 12
Earnings call
Revenue up 62.3%; around 500 crores targeted

Prostam Info Systems Limited reported first-half revenue from operations of INR 196 crores, up 62.3%, and targets around 500 crores for the current financial year. It expects EBITDA margin above 11% this year, 12 to 13 percent next year and at least 25% growth.

7 source passages
On behalf of Arian Capital Markets Limited, I thank you all for joining into the Q2 and a full after FY26 earnings call conference of Prostam Info Systems Limited. Against this backdrop, we delivered a strong performance during the first half of financial year 27. With revenue from operations growing 62.3% year-on-year to INR 196 crores given by Healthy Order Execution. we are well positioned to have around 500 crores of revenue being booked in the current financial year. We would try to maintain the parity, but still it should be above 11%. 12 to 13 percent. 25% is the minimum expectation that we are keeping an eye for next financial year. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
· 820.20M INR 67.95M INR '25 Q4 · 549.14M INR 17.65M INR '26 Q1 · 659.15M INR 81.70M INR '26 Q2 · 1.60B INR 0 INR '26 Q3 ▲27.4% 1.04B INR 0 INR '26 Q4 LATEST ▲38.5% 760.48M INR 45.79M INR '27 Q1

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 115.35 INR Now 131.30 INR · 20% Range high 194.55 INR
vs 200-day avg -6% vs 50-day avg +0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:PROSTARM -3.8% -1.2% -17.2% +5.9% -26.3%

Exchange listing

Market
XBOM
Ticker
PROSTARM
ISIN
INE0BX301013
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.prostarm.com/
Investor relations
https://prostarm.com/investor/disclosures-under-regulation-46-of-the-sebi-lodr/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-12 Audio Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-13 Audio Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-25 Transcript
    Earnings Call for the Quarter Ended March 31, 2026